Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Douglas Hawkins

Outcome of Patients With Localized Orbital Sarcoma Who Relapsed Following Treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-Iii and -IV, 1984-1997: A Report From the Children's Oncology Group

Pediatric Blood and Cancer

English

Association of Serum Progranulin Levels With Disease Progression and Decreased Survival in Metastatic Breast Cancer Patients

Clinical Breast Cancer

Cancer Research

Oncology

2019

English

Related publications

Local Control and Outcome in Children With Localized Vaginal Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Pediatric Blood and Cancer

English

Early Treatment Failure in Intermediate-Risk Rhabdomyosarcoma: Results From IRS-IV and D9803—A Report From the Children's Oncology Group

Journal of Clinical Oncology

English

Phase II Study of Intermediate-Dose Cytarabine in Patients With Relapsed or Refractory Ewing Sarcoma: A Report From the Children's Oncology Group

Pediatric Blood and Cancer

English

TumoralTP53and/orCDKN2Aalterations Are Not Reliable Prognostic Biomarkers in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group

Pediatric Blood and Cancer

English

Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group

Pediatric Blood and Cancer

English

Patterns of Chemotherapy-Induced Toxicities and Outcome in Children and Adolescents With Metastatic Rhabdomyosarcoma: A Report From the Children's Oncology Group

Pediatric Blood and Cancer

English

Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group

International Journal of Radiation Oncology Biology Physics

English

AAML0523: A Report From the Children's Oncology Group on the Efficacy of Clofarabine in Combination With Cytarabine in Pediatric Patients With Relapsed Acute Myeloid Leukemia

English

Genomic and Outcome Analyses of Ph-Like ALL in NCI Standard-Risk Patients: A Report From the Children's Oncology Group

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Douglas Hawkins

Outcome of Patients With Localized Orbital Sarcoma Who Relapsed Following Treatment on Intergroup Rhabdomyosarcoma Study Group (IRSG) Protocols-Iii and -IV, 1984-1997: A Report From the Children's Oncology Group

Association of Serum Progranulin Levels With Disease Progression and Decreased Survival in Metastatic Breast Cancer Patients

Related publications

Local Control and Outcome in Children With Localized Vaginal Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Early Treatment Failure in Intermediate-Risk Rhabdomyosarcoma: Results From IRS-IV and D9803—A Report From the Children's Oncology Group

Phase II Study of Intermediate-Dose Cytarabine in Patients With Relapsed or Refractory Ewing Sarcoma: A Report From the Children's Oncology Group

TumoralTP53and/orCDKN2Aalterations Are Not Reliable Prognostic Biomarkers in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group

Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group

Patterns of Chemotherapy-Induced Toxicities and Outcome in Children and Adolescents With Metastatic Rhabdomyosarcoma: A Report From the Children's Oncology Group

Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group

AAML0523: A Report From the Children's Oncology Group on the Efficacy of Clofarabine in Combination With Cytarabine in Pediatric Patients With Relapsed Acute Myeloid Leukemia

Genomic and Outcome Analyses of Ph-Like ALL in NCI Standard-Risk Patients: A Report From the Children's Oncology Group